Sequoia China Acquires Cardiovascular Device Upstream Supplier
Sequoia China has secured an 80% controlling stake in PeierTech, a veteran Chinese manufacturer of medical‑grade Nitinol alloy and contract manufacturing services for interventional medical devices. The deal represents the firm’s first controlling buyout focused on medical device upstream materials, highlighting growing investor interest in domestic supply chain resilience for cardiovascular and minimally invasive device segments.
October 9, 2026
Nearly RMB 100 Million Raised: Qubot’s Neurointerventional Robot Combines Magnetic Guidewire Control With a VLA Model
Qubot Technology has raised nearly RMB 100 million in a Pre-A+ round to advance Maxwell, its neurointerventional robotic platform combining magnetic distal-tip guidewire control, 4D-DSA imaging and a VLA foundation model, with the long-term goal of automated mechanical thrombectomy.
September 19, 2026
Focusing on Procedure Adaptation: How WEISEBOT Is Iterating Its Laparoscopic Surgical Robot
WEISEBOT is expanding its laparoscopic surgical robotics platform around procedure-specific clinical needs, with new developments in energy instruments, bipolar sealing, extended curved scissors and system integration aimed at supporting more complex general surgery workflows.
September 12, 2026
20 Chinese MedTech Companies Global Executives Should Know in 2026
From high-end imaging and cardiovascular implants to diagnostics and surgical robotics, Chinese MedTech companies are moving rapidly up the value chain—and increasingly into global markets. This guide profiles 20 companies international executives should know, outlining what they make, where they compete and why they matter in 2026.
August 18, 2026
TIROMU Secures Pre-A Financing to Advance Ophthalmic Surgical Robotics
TIROMU raised tens of millions of RMB in Pre-A funding to advance clinical trials and registration filing for its fundus injection surgical robot, while continuing R&D on next-generation ophthalmic microsurgery systems.
May 4, 2026








